Medical Use of Byproduct Material; Working Group for Revision

Короткий зміст

A working group consisting of representatives from the U.S. Nuclear Regulatory Commission, the Organization of Agreement States (OAS), and the Conference of Radiation Control Program Directors (CRCPD) has been established in response to Commission approval of the staff's proposed plan for revising 10 CFR part 35, associated guidance documents, and the Commission's 1979 ``Medical Policy Statement,'' if necessary. With this approval, the NRC staff has begun developing draft rule language and alternatives, using an entirely modality-based approach, to help focus the public input and the discussions during facilitated public meetings. During this process, the staff is examining the applicability of risk-informed, performance-based regulations and less prescriptive approaches to regulation of nuclear material used for medical purposes. The working group will meet at NRC Headquarters in Rockville, Maryland, on August 19 and August 20, 1997, to review the early draft staff documents and to discuss the major regulatory issues associated with the medical use of byproduct material.